2;256:651-8.
52. Nelissen BG, Herwaarden JA, Pasterkamp G, Moll FL,
Vaartjes I. Shifting abdominal aortic aneurysm mortality
trends in The Netherlands. J Vasc Surg 2015;61:642-7.e2.
53. Sidloff D, Stather P, Dattani N, Bown M, Thompson J,
Sayers R, et al. Aneurysm global epidemiology study: public
health measures can further reduce abdominal aortic
aneurysm mortality. Circulation 2014;129:747-53.
54. Wang S, Zhang C, Zhang M, Liang B, Zhu H, Lee J, et al.
Activation of AMP-activated protein kinase a2 by nicotine
instigates formation of abdominal aortic aneurysms in
mice in vivo. Nat Med 2012;18:902-10.
55. Li ZZ, Dai QY. Pathogenesis of abdominal aortic aneurysms:
role of nicotine and nicotinic acetylcholine receptors. Mediators Inï¬‚amm 2012;2012:103120.
56. Maegdefessel L, Azuma J, Toh R, Deng A, Merk DR,
Raiesdana A, et al. MicroRNA-21 blocks abdominal aortic

aneurysm development and nicotine-augmented expansion. Sci Transl Med 2012;4:122ra22.
57. Brown LC, Powell JT. Risk factors for aneurysm rupture in
patients kept under ultrasound surveillance. UK Small
Aneurysm Trial Participants. Ann Surg 1999;230:289-96.
58. Brown PM, Zelt DT, Sobolev B. The risk of rupture in untreated aneurysms: the impact of size, gender, and expansion rate. J Vasc Surg 2003;37:280-4.
59. Cronenwett JL, Murphy TF, Zelenock GB, Whitehouse WM Jr,
Lindenauer SM, Graham LM, et al